|
ZNF532 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.717200E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.164300E-03 |
| Normal-vs-Stage2 |
7.413000E-01 |
| Normal-vs-Stage3 |
2.636400E-02 |
| Normal-vs-Stage4 |
6.951700E-02 |
| Stage1-vs-Stage2 |
9.175600E-02 |
| Stage1-vs-Stage3 |
8.438400E-01 |
| Stage1-vs-Stage4 |
4.488000E-01 |
| Stage2-vs-Stage3 |
1.761960E-01 |
| Stage2-vs-Stage4 |
3.350000E-01 |
| Stage3-vs-Stage4 |
6.456000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.637200E-03 |
| Normal-vs-AfricanAmerican |
4.011900E-02 |
| Normal-vs-Asian |
1.484820E-03 |
| Caucasian-vs-AfricanAmerican |
4.419000E-01 |
| Caucasian-vs-Asian |
3.411200E-01 |
| AfricanAmerican-vs-Asian |
9.501200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.145700E-02 |
| Normal-vs-Female |
8.438000E-03 |
| Male-vs-Female |
6.821400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.175500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.165740E-02 |
| Normal-vs-Age(61-80Yrs) |
5.011400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.120200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.545000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.000200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.759080E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.931700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.117500E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.212560E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.866800E-01 |
| Classical-VS-Follicular |
6.26779739221206E-11 |
| Classical-VS-Other |
7.403400E-01 |
| Classical-VS-Normal |
2.974700E-04 |
| Tall-VS-Follicular |
2.817800E-04 |
| Tall-VS-Other |
6.855000E-01 |
| Tall-VS-Normal |
5.342200E-03 |
| Follicular-VS-Other |
9.764000E-02 |
| Follicular-VS-Normal |
1.003360E-01 |
| Other-VS-Normal |
1.972390E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.091400E-01 |
| Normal-vs-N1 |
1.597610E-02 |
| N0-vs-N1 |
1.036980E-01 |
|
|
